BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32117854)

  • 1. Identification of Immune Responses to Japanese Encephalitis Virus Specific T Cell Epitopes.
    Pushpakumara PD; Jeewandara C; Wijesinghe A; Gomes L; Ogg GS; Goonasekara CL; Malavige GN
    Front Public Health; 2020; 8():19. PubMed ID: 32117854
    [No Abstract]   [Full Text] [Related]  

  • 2. Development and validation of an assay for detection of Japanese encephalitis virus specific antibody responses.
    Pushpakumara PD; Jeewandara C; Gomes L; Perera Y; Wijewickrama A; Malavige GN; Goonesekara C
    PLoS One; 2020; 15(10):e0238609. PubMed ID: 33112881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular Immune Responses to Live Attenuated Japanese Encephalitis (JE) Vaccine SA14-14-2 in Adults in a JE/Dengue Co-Endemic Area.
    Turtle L; Tatullo F; Bali T; Ravi V; Soni M; Chan S; Chib S; Venkataswamy MM; Fadnis P; Yaïch M; Fernandez S; Klenerman P; Satchidanandam V; Solomon T
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005263. PubMed ID: 28135273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.
    Prompetchara E; Ketloy C; Keelapang P; Sittisombut N; Ruxrungtham K
    Asian Pac J Allergy Immunol; 2015 Sep; 33(3):182-8. PubMed ID: 26342114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functionality of dengue virus specific memory T cell responses in individuals who were hospitalized or who had mild or subclinical dengue infection.
    Jeewandara C; Adikari TN; Gomes L; Fernando S; Fernando RH; Perera MK; Ariyaratne D; Kamaladasa A; Salimi M; Prathapan S; Ogg GS; Malavige GN
    PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003673. PubMed ID: 25875020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human T cell responses to Japanese encephalitis virus in health and disease.
    Turtle L; Bali T; Buxton G; Chib S; Chan S; Soni M; Hussain M; Isenman H; Fadnis P; Venkataswamy MM; Satishkumar V; Lewthwaite P; Kurioka A; Krishna S; Shankar MV; Ahmed R; Begum A; Ravi V; Desai A; Yoksan S; Fernandez S; Willberg CB; Kloverpris HN; Conlon C; Klenerman P; Satchidanandam V; Solomon T
    J Exp Med; 2016 Jun; 213(7):1331-52. PubMed ID: 27242166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults.
    Saito Y; Moi ML; Takeshita N; Lim CK; Shiba H; Hosono K; Saijo M; Kurane I; Takasaki T
    BMC Infect Dis; 2016 Oct; 16(1):578. PubMed ID: 27756212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of serotype-specific T cell responses to highly conserved regions of the dengue viruses.
    Malavige GN; McGowan S; Atukorale V; Salimi M; Peelawatta M; Fernando N; Jayaratne SD; Ogg G
    Clin Exp Immunol; 2012 May; 168(2):215-23. PubMed ID: 22471283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cultured ELISpot Assay to Investigate Dengue Virus Specific T-Cell Responses.
    Jeewandara C; Ogg GS; Malavige GN
    Methods Mol Biol; 2018; 1808():165-171. PubMed ID: 29956182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Japanese encephalitis virus prM-E antigen immunization conferred protection against challenge by four different serotypes of Dengue viruses in mice.
    Gao N; Li J; Sheng Z; Chen H; Fan D; Wang P; An J
    Appl Microbiol Biotechnol; 2019 Jun; 103(12):4977-4986. PubMed ID: 31037380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of a virus-specific continuous B-cell epitope on the PrM/M protein of Japanese Encephalitis Virus: potential application in the detection of antibodies to distinguish Japanese Encephalitis Virus infection from West Nile Virus and Dengue Virus infections.
    Hua RH; Chen NS; Qin CF; Deng YQ; Ge JY; Wang XJ; Qiao ZJ; Chen WY; Wen ZY; Liu WX; Hu S; Bu ZG
    Virol J; 2010 Sep; 7():249. PubMed ID: 20858291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change in Dengue and Japanese Encephalitis Seroprevalence Rates in Sri Lanka.
    Jeewandara C; Gomes L; Paranavitane SA; Tantirimudalige M; Panapitiya SS; Jayewardene A; Fernando S; Fernando RH; Prathapan S; Ogg GS; Malavige GN
    PLoS One; 2015; 10(12):e0144799. PubMed ID: 26696417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated immune responses to different formulations of a live-attenuated tetravalent dengue vaccine candidate in subjects living in dengue endemic and non-endemic regions.
    Moris P; Bauer KM; Currier JR; Friberg H; Eckels KH; Esquilin IO; Gibbons RV; Innis BL; Jarman RG; Simasathien S; Sun P; Thomas SJ; Watanaveeradej V
    Hum Vaccin Immunother; 2019; 15(9):2090-2105. PubMed ID: 30829100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive mapping of a novel NS1 epitope conserved in flaviviruses within the Japanese encephalitis virus serocomplex.
    Hua RH; Liu LK; Huo H; Li YN; Guo LP; Wang XL; Qin CF; Bu ZG
    Virus Res; 2014 Jun; 185():103-9. PubMed ID: 24631788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of chimeric Japanese encephalitis and dengue viruses for use in diagnostic plaque reduction neutralization tests.
    Johnson BW; Kosoy O; Hunsperger E; Beltran M; Delorey M; Guirakhoo F; Monath T
    Clin Vaccine Immunol; 2009 Jul; 16(7):1052-9. PubMed ID: 19458204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of cross-reactivity between flaviviruses with sera of patients with Japanese encephalitis showed the importance of neutralization tests for the diagnosis of Japanese encephalitis.
    Maeki T; Tajima S; Ikeda M; Kato F; Taniguchi S; Nakayama E; Takasaki T; Lim CK; Saijo M
    J Infect Chemother; 2019 Oct; 25(10):786-790. PubMed ID: 31105002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the protective ability of plasma from Japanese individuals against mosquito-borne viral infections.
    Shinohara N; Owada T; Matsumoto C; Uchida S; Nagai T; Satake M; Tadokoro K
    Trans R Soc Trop Med Hyg; 2017 Sep; 111(9):393-401. PubMed ID: 29294131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Japanese Encephalitis DNA Vaccines with Epitope Modification Reduce the Induction of Cross-Reactive Antibodies against Dengue Virus and Antibody-Dependent Enhancement of Dengue Virus Infection.
    Kotaki T; Nagai Y; Yamanaka A; Konishi E; Kameoka M
    Vaccines (Basel); 2022 Aug; 10(9):. PubMed ID: 36146489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of immunodominant, group-specific and subcomplex-specific, continuous epitopes in the core regions of Japanese encephalitis virus using synthetic peptides.
    Huang JH; Wey JJ; Lee HF; Tsou TL; Wu CS; Wu JR; Chen HM; Chin C; Chien LJ; Chen LK; Wu YC; Pan MJ; Wang TM
    Virus Res; 1996 Mar; 41(1):43-53. PubMed ID: 8725101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of cytotoxic T lymphocyte epitopes in dengue virus serotype 1.
    Duan Z; Guo J; Huang X; Liu H; Chen X; Jiang M; Wen J
    J Med Virol; 2015 Jul; 87(7):1077-89. PubMed ID: 25777343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.